Leading five global anti-viral products by revenue 2017 and 2024
This statistic displays the top 5 global anti-viral products base on their revenue worldwide in 2017, and a projection for 2024. Gilead Sciences' Genvoya is expected to generate 3.4 billion U.S. dollars in revenues by 2024.